Puslapis 1 nuo 32 rezultatus
The present invention relates to a novel pharmaceutical use of dihydropyridine derivatives of formula I ##STR1## wherein R.sub.1 is hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl or alkinyl of 3 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, cycloalkylalkyl of 4 to 8 carbon atoms,
BACKGROUND OF THE INVENTION
The present invention relates to a new method for the treatment of vascular (migraine, cluster) and tension headaches and atypical facial pain.
In accordance with the invention, the method of treatment for these headaches and atypical facial pain consists of the
FIELD OF THE INVENTION
The present invention relates to a method for the prophylaxis of vascular headaches which do not originate from hypertension, especially migraine, the method comprising administration of {4'-[2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazol-1-ylme-
BACKGROUND OF THE INVENTION
TECHNICAL FIELD
This invention relates to a method for reducing or relieving symptoms associated with vascular headaches, including migraine headaches, by administering to a person exhibiting vascular headache symptomatology a therapeutically effective amount of a
BACKGROUND OF THE INVENTION
This invention generally pertains to heterocyclic carbon compounds having drug and bio-affecting properties and to their preparation and use. In particular the invention is concerned with 1,4-disubstituted piperazine derivatives wherein one substituent moiety is an
FIELD OF THE INVENTION
This invention is concerned with a drug bio-affecting body-treating process which employs the benzisothiazole compound 8-[4-[4-(1,2-benzisothiazol-3-yl)-l-piperazinyl]-butyl]-8-azaspiro(4.5)dec ane-7,9-dione or a pharmaceutically acceptable acid addition salt
BACKGROUND
Migraine headache ("migraine") is a common disorder, believed to afflict 20 to 30 percent of the population at large. In migraine patients, throbbing head pain occurs periodically. The pain often is associated with symptoms such as nausea, vomiting and impaired vision. Migraine is a
BACKGROUND
Migraine headache ("migraine") is a common disorder, believed to afflict 20 to 30 percent of the population at large. In migraine patients, throbbing head pain occurs periodically. The pain often is associated with symptoms such as nausea, vomiting and impaired vision. Migraine is a
BACKGROUND OF THE PRESENT INVENTION
The present invention is novel compounds, which are derivatives of benzoic acid and benzoic acid esters--having antiinflammatory activity for the treatment of arthritis, asthma, Raynaud's disease, inflammatory bowel disorders, trigeminal or herpetic neuralgia,
This invention relates to electronic pain suppression apparatus and methodology and, more specifically, to headache modulator apparatus and procedure for eliminating, reducing or controlling headache syndromes to specifically include those referred to as migraine or vascular. The word "migraine" as
BACKGROUND OF THE INVENTION
The present invention is novel compounds, which are of 4'-hydroxyphenylacetic acid having antiinflammatory activity for the treatment of arthritis, asthma, Raynaud's disease, inflammatory bowel disorders, trigeminal or herpetic neuralgia, inflammatory eye disorders,
FIELD OF THE INVENTION
The present invention relates to the use of an angiotensin II (AT II) type 1 receptor antagonist in the manufacture of a medicament for the prophylactic and/or therapeutic treatment of vascular headaches, and in particular as a medicament for the treatment of migraine. The
BACKGROUND OF THE PRESENT INVENTION
The present invention is novel compounds, which are derivatives of benzoic acid and benzoic acid esters--having antiinflammatory activity for the treatment of arthritis, asthma, Raynaud's disease, inflammatory bowel disorders, trigeminal or herpetic neuralgia,
BACKGROUND OF THE PRESENT INVENTION
The present invention is novel compounds, which are derivatives of benzoic acid and benzoic acid esters--having antiinflammatory activity for the treatment of arthritis, asthma, Raynaud's disease, inflammatory bowel disorders, trigeminal or herpetic neuralgia,
BACKGROUND OF THE PRESENT INVENTION
The present invention is novel compounds, which are derivatives of benzoic acid and benzoic acid esters--having antiinflammatory activity for the treatment of arthritis, asthma, Raynaud's disease, inflammatory bowel disorders, trigeminal or herpetic neuralgia,